東華大學圖書館 |

Model organisms for microbial pathogenesis, biofilm formation and antimicrobial drug discovery

Record Type:	Electronic resources : Monograph/item
Title/Author:	Model organisms for microbial pathogenesis, biofilm formation and antimicrobial drug discovery/ edited by Busi Siddhardha, Madhu Dyavaiah, Asad Syed.
other author:	Siddhardha, Busi.
Published:	Singapore :Springer Singapore : : 2020.,
Description:	xvii, 684 p. :ill., digital ;24 cm.
[NT 15003449]:	Chapter 1. Microbial infections and virulence factors -- Chapter 2. Microbial Pathogenesis: Virus pathogen-host interactions -- Chapter 3. A physical insight of biofilms -- Chapter 4. A Review on Microbial Pathogenesis and Host Response -- Chapter 5. Role of quorum sensing in microbial infections and biofilm formation -- Chapter 6. Microbial Pathogenesis and Antimicrobial Drug Resistance -- Chapter 7. Pathogenesis and antibiotic resistance of Staphylococcus aureus -- Chapter 8. Pathogenesis, Virulence factors and Antibiotic resistance of Group B Streptococcus -- Chapter 9. Enterococcal infections and Drug resistance mechanisms -- Chapter 10. Pathogenic Escherichia coli: Virulence factors and their Antimicrobial resistance -- Chapter 11. Enterobacter Infections and antimicrobial drug resistance -- Chapter 12. Klebsiella pneumoniae infections and antimicrobial drug resistance -- Chapter 13. Pathogenesis and drug resistance of Pseudomonas aeruginosa -- Chapter 14. Acinetobacter baumannii: Infections and drug resistance -- Chapter 15. Vibrio cholera: Mechanisms of Pathogenicity and Antibiotic resistance -- Chapter 16. Current trends in Mycobacterium tuberculosis pathogenesis and drug resistance -- Chapter 17. PATHOGENESIS OF FUNGAL INFECTIONS AND DRUG- RESISTANCE PHENOMENON -- Chapter 18. Pathogenesis and drug resistance profile of food-borne pathogens -- Chapter 19. Cell lines as in vitro model for studying microbial pathogenesis -- Chapter 20. Animal models to understand host-pathogen interactions -- Chapter 21. Caenorhabditis elegans as pathogenesis model to understand bacterial virulence -- Chapter 22. Zebra fish infection model: From pathogenesis to therapeutics -- Chapter 23. Mycobacterium pathogenesis and drug discovery: Looking through the zebra fish keyhole -- Chapter 24. Murine models to study acute and chronic bacterial infections -- Chapter 25. Non-human primate model use in understanding infectious diseases -- Chapter 26. Understanding Biofilm Dynamics: In Vitro and In Vivo Models -- Chapter 27. Model organisms and antimicrobial drug discovery -- Chapter 28. Yeast: A model organism for antimicrobial drug discovery -- Chapter 29. Caenorhabditis elegans: A tool for antimicrobial drug discovery -- Chapter 30. Zebrafish Model System in Antimicrobial Drug Discovery -- Chapter 31. Murine Models for Development of Anti-Infective Therapeutics -- Chapter 32. Non-human primate models for antimicrobial drug discovery.
Contained By:	Springer eBooks
Subject:	Pathogenic microorganisms. -
Online resource:	https://doi.org/10.1007/978-981-15-1695-5
ISBN:	9789811516955

Model organisms for microbial pathogenesis, biofilm formation and antimicrobial drug discovery
Model organisms for microbial pathogenesis, biofilm formation and antimicrobial drug discovery[electronic resource] /edited by Busi Siddhardha, Madhu Dyavaiah, Asad Syed. - Singapore :Springer Singapore :2020. - xvii, 684 p. :ill., digital ;24 cm.

Chapter 1. Microbial infections and virulence factors -- Chapter 2. Microbial Pathogenesis: Virus pathogen-host interactions -- Chapter 3. A physical insight of biofilms -- Chapter 4. A Review on Microbial Pathogenesis and Host Response -- Chapter 5. Role of quorum sensing in microbial infections and biofilm formation -- Chapter 6. Microbial Pathogenesis and Antimicrobial Drug Resistance -- Chapter 7. Pathogenesis and antibiotic resistance of Staphylococcus aureus -- Chapter 8. Pathogenesis, Virulence factors and Antibiotic resistance of Group B Streptococcus -- Chapter 9. Enterococcal infections and Drug resistance mechanisms -- Chapter 10. Pathogenic Escherichia coli: Virulence factors and their Antimicrobial resistance -- Chapter 11. Enterobacter Infections and antimicrobial drug resistance -- Chapter 12. Klebsiella pneumoniae infections and antimicrobial drug resistance -- Chapter 13. Pathogenesis and drug resistance of Pseudomonas aeruginosa -- Chapter 14. Acinetobacter baumannii: Infections and drug resistance -- Chapter 15. Vibrio cholera: Mechanisms of Pathogenicity and Antibiotic resistance -- Chapter 16. Current trends in Mycobacterium tuberculosis pathogenesis and drug resistance -- Chapter 17. PATHOGENESIS OF FUNGAL INFECTIONS AND DRUG- RESISTANCE PHENOMENON -- Chapter 18. Pathogenesis and drug resistance profile of food-borne pathogens -- Chapter 19. Cell lines as in vitro model for studying microbial pathogenesis -- Chapter 20. Animal models to understand host-pathogen interactions -- Chapter 21. Caenorhabditis elegans as pathogenesis model to understand bacterial virulence -- Chapter 22. Zebra fish infection model: From pathogenesis to therapeutics -- Chapter 23. Mycobacterium pathogenesis and drug discovery: Looking through the zebra fish keyhole -- Chapter 24. Murine models to study acute and chronic bacterial infections -- Chapter 25. Non-human primate model use in understanding infectious diseases -- Chapter 26. Understanding Biofilm Dynamics: In Vitro and In Vivo Models -- Chapter 27. Model organisms and antimicrobial drug discovery -- Chapter 28. Yeast: A model organism for antimicrobial drug discovery -- Chapter 29. Caenorhabditis elegans: A tool for antimicrobial drug discovery -- Chapter 30. Zebrafish Model System in Antimicrobial Drug Discovery -- Chapter 31. Murine Models for Development of Anti-Infective Therapeutics -- Chapter 32. Non-human primate models for antimicrobial drug discovery.

This book provides essential insights into microbial pathogenesis, host-pathogen interactions, and the anti-microbial drug resistance of various human pathogens on the basis of various model organisms. The initial sections of the book introduce readers to the mechanisms of microbial pathogenesis, host-pathogen interactions, anti-microbial drug resistance, and the dynamics of biofilm formation. Due to the emergence of various microbial resistant strains, it is especially important to understand the prognosis for microbial infections, disease progression profiles, and mechanisms of resistance to antibiotic therapy in order to develop novel therapeutic strategies. In turn, the second part of the book presents a comparative analysis of various animal models to help readers understand microbial pathogenesis, host-pathogen interactions, anti-microbial drug discovery, anti-biofilm therapeutics, and treatment regimes. Given its scope, the book represents a valuable asset for microbiologists, biotechnologists, medical professionals, drug development researchers, and pharmacologists alike.

ISBN: 9789811516955

Standard No.: 10.1007/978-981-15-1695-5doiSubjects--Topical Terms:

545857
Pathogenic microorganisms.

LC Class. No.: QR46 / .M634 2020

Dewey Class. No.: 616.01

Model organisms for microbial pathogenesis, biofilm formation and antimicrobial drug discovery
LDR:04604nmm a2200325 a 4500 001 2216757
003 DE-He213
005 20200727142013.0
006 m d
007 cr nn 008maaau
008 201120s2020 si s 0 eng d
020 $a 9789811516955 $q (electronic bk.)
020 $a 9789811516948 $q (paper)
024 7 $a 10.1007/978-981-15-1695-5 $2 doi
035 $a 978-981-15-1695-5
040 $a GP $c GP
041 0 $a eng
050 4 $a QR46 $b .M634 2020
072 7 $a PSG $2 bicssc
072 7 $a SCI045000 $2 bisacsh
072 7 $a PSG $2 thema
082 0 4 $a 616.01 $2 23
090 $a QR46 $b .M689 2020
245 0 0 $a Model organisms for microbial pathogenesis, biofilm formation and antimicrobial drug discovery $h [electronic resource] / $c edited by Busi Siddhardha, Madhu Dyavaiah, Asad Syed.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2020.
300 $a xvii, 684 p. : $b ill., digital ; $c 24 cm.
505 0 $a Chapter 1. Microbial infections and virulence factors -- Chapter 2. Microbial Pathogenesis: Virus pathogen-host interactions -- Chapter 3. A physical insight of biofilms -- Chapter 4. A Review on Microbial Pathogenesis and Host Response -- Chapter 5. Role of quorum sensing in microbial infections and biofilm formation -- Chapter 6. Microbial Pathogenesis and Antimicrobial Drug Resistance -- Chapter 7. Pathogenesis and antibiotic resistance of Staphylococcus aureus -- Chapter 8. Pathogenesis, Virulence factors and Antibiotic resistance of Group B Streptococcus -- Chapter 9. Enterococcal infections and Drug resistance mechanisms -- Chapter 10. Pathogenic Escherichia coli: Virulence factors and their Antimicrobial resistance -- Chapter 11. Enterobacter Infections and antimicrobial drug resistance -- Chapter 12. Klebsiella pneumoniae infections and antimicrobial drug resistance -- Chapter 13. Pathogenesis and drug resistance of Pseudomonas aeruginosa -- Chapter 14. Acinetobacter baumannii: Infections and drug resistance -- Chapter 15. Vibrio cholera: Mechanisms of Pathogenicity and Antibiotic resistance -- Chapter 16. Current trends in Mycobacterium tuberculosis pathogenesis and drug resistance -- Chapter 17. PATHOGENESIS OF FUNGAL INFECTIONS AND DRUG- RESISTANCE PHENOMENON -- Chapter 18. Pathogenesis and drug resistance profile of food-borne pathogens -- Chapter 19. Cell lines as in vitro model for studying microbial pathogenesis -- Chapter 20. Animal models to understand host-pathogen interactions -- Chapter 21. Caenorhabditis elegans as pathogenesis model to understand bacterial virulence -- Chapter 22. Zebra fish infection model: From pathogenesis to therapeutics -- Chapter 23. Mycobacterium pathogenesis and drug discovery: Looking through the zebra fish keyhole -- Chapter 24. Murine models to study acute and chronic bacterial infections -- Chapter 25. Non-human primate model use in understanding infectious diseases -- Chapter 26. Understanding Biofilm Dynamics: In Vitro and In Vivo Models -- Chapter 27. Model organisms and antimicrobial drug discovery -- Chapter 28. Yeast: A model organism for antimicrobial drug discovery -- Chapter 29. Caenorhabditis elegans: A tool for antimicrobial drug discovery -- Chapter 30. Zebrafish Model System in Antimicrobial Drug Discovery -- Chapter 31. Murine Models for Development of Anti-Infective Therapeutics -- Chapter 32. Non-human primate models for antimicrobial drug discovery.
520 $a This book provides essential insights into microbial pathogenesis, host-pathogen interactions, and the anti-microbial drug resistance of various human pathogens on the basis of various model organisms. The initial sections of the book introduce readers to the mechanisms of microbial pathogenesis, host-pathogen interactions, anti-microbial drug resistance, and the dynamics of biofilm formation. Due to the emergence of various microbial resistant strains, it is especially important to understand the prognosis for microbial infections, disease progression profiles, and mechanisms of resistance to antibiotic therapy in order to develop novel therapeutic strategies. In turn, the second part of the book presents a comparative analysis of various animal models to help readers understand microbial pathogenesis, host-pathogen interactions, anti-microbial drug discovery, anti-biofilm therapeutics, and treatment regimes. Given its scope, the book represents a valuable asset for microbiologists, biotechnologists, medical professionals, drug development researchers, and pharmacologists alike.
650 0 $a Pathogenic microorganisms. $3 545857
650 0 $a Host-parasite relationships. $3 905699
650 0 $a Drug resistance in microorganisms. $3 669099
650 0 $a Communicable diseases $x Pathogenesis. $3 720460
650 0 $a Biofilms. $3 660574
650 0 $a Anti-infective agents. $3 634368
650 1 4 $a Microbiology. $3 536250
650 2 4 $a Medical Microbiology. $3 890951
650 2 4 $a Animal Models. $3 1001014
650 2 4 $a Infectious Diseases. $3 894100
700 1 $a Siddhardha, Busi. $3 3449430
700 1 $a Dyavaiah, Madhu. $3 3449431
700 1 $a Syed, Asad. $3 3449432
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u https://doi.org/10.1007/978-981-15-1695-5
950 $a Biomedical and Life Sciences (Springer-11642)